VYNE Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bridgewater, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
VYNE Therapeutics Inc. has filed 659 SEC EDGAR filings since 07 Jan 2013

SEC filing history

Showing 476-500 of 659 matching filings.

Per page
25
Current page
20
3

FORM 3 SUBMISSION

Filing date
11 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
11 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
11 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
11 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
11 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

FORM 8-K

Filing date
10 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-237041

FORM S-8

Filing date
09 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
03 Mar 2020
Reporting date
03 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90268

SC 13G/A filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90268

JANUS HENDERSON GROUP PLC OWNS 5.3% OF MENLO

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
06 Feb 2020
Reporting date
06 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
425

8-K

Filing date
06 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90268

NONE

Filing date
04 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
28 Jan 2020
Reporting date
21 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
425

8-K

Filing date
28 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90268

SCHEDULE 13G

Filing date
21 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
16 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
16 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38356

8-K

Filing date
15 Jan 2020
Reporting date
07 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
425

8-K

Filing date
15 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-235351

EFFECT filing

Filing date
07 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-235351

424B3

Filing date
07 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-4/A File 333-235351

S-4/A

Filing date
06 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .